Antibody Immunity and Invasive Fungal Infections

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1995 Nov 1

PMID 7591049

Citations 91

Authors

A Casadevall

Affiliations

Soon will be listed here.

Citing Articles

IL-6 deficiency accelerates cerebral cryptococcosis and alters glial cell responses.

Reguera-Gomez M, Munzen M, Hamed M, Charles-Nino C, Martinez L J Neuroinflammation. 2024; 21(1):242.

PMID: 39334365 PMC: 11437997. DOI: 10.1186/s12974-024-03237-x.

Insight into Virulence and Mechanisms of Amphotericin B Resistance in the Complex.

Huang Y, Su Y, Chen X, Xiao M, Xu Y J Fungi (Basel). 2024; 10(9).

PMID: 39330375 PMC: 11433262. DOI: 10.3390/jof10090615.

Immunotherapies against human bacterial and fungal infectious diseases: A review.

Qadri H, Shah A, Alkhanani M, Almilaibary A, Mir M Front Med (Lausanne). 2023; 10:1135541.

PMID: 37122338 PMC: 10140573. DOI: 10.3389/fmed.2023.1135541.

B Cell Recognition of Hyphae TLR 2 Promotes IgG1 and IL-6 Secretion for T17 Differentiation.

Ferreira-Gomes M, Wich M, Bode S, Hube B, Jacobsen I, Jungnickel B Front Immunol. 2021; 12:698849.

PMID: 34819929 PMC: 8606576. DOI: 10.3389/fimmu.2021.698849.

Immunotherapy against Systemic Fungal Infections Based on Monoclonal Antibodies.

Boniche C, Rossi S, Kischkel B, Barbalho F, Moura A, Nosanchuk J J Fungi (Basel). 2020; 6(1).

PMID: 32121415 PMC: 7151209. DOI: 10.3390/jof6010031.

References

Mazanec M, Kaetzel C, Lamm M, Fletcher D, Nedrud J . Intracellular neutralization of virus by immunoglobulin A antibodies. Proc Natl Acad Sci U S A. 1992; 89(15):6901-5. PMC: 49612. DOI: 10.1073/pnas.89.15.6901. View

Brueske C . Proteolytic activity of a clinical isolate of Cryptococcus neoformans. J Clin Microbiol. 1986; 23(3):631-3. PMC: 268711. DOI: 10.1128/jcm.23.3.631-633.1986. View

Mukherjee J, Feldmesser M, Scharff M, Casadevall A . Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy. Antimicrob Agents Chemother. 1995; 39(7):1398-405. PMC: 162752. DOI: 10.1128/AAC.39.7.1398. View

Bohler K, Klade H, Poitschek C, Reinthaller A . Immunohistochemical study of in vivo and in vitro IgA coating of candida species in vulvovaginal candidiasis. Genitourin Med. 1994; 70(3):182-6. PMC: 1195227. DOI: 10.1136/sti.70.3.182. View

La Mantia L, Salmaggi A, Tajoli L, Cerrato D, Lamperti E, Nespolo A . Cryptococcal meningoencephalitis: intrathecal immunological response. J Neurol. 1986; 233(6):362-6. DOI: 10.1007/BF00313923. View

Mourad S, Friedman L . Passive immunization of mice against Candida albicans. Sabouraudia. 1968; 6(2):103-5. View

Neely A, Holder I . Effects of immunoglobulin G and low-dose amphotericin B on Candida albicans infections in burned mice. Antimicrob Agents Chemother. 1992; 36(3):643-6. PMC: 190571. DOI: 10.1128/AAC.36.3.643. View

Sarosi G, Parker J, DOTO I, TOSH F . Amphotericin B in cryptococcal meningitis. Long-term results of treatment. Ann Intern Med. 1969; 71(6):1079-87. DOI: 10.7326/0003-4819-71-6-1079. View

Henderson D, Kan V, Bennett J . Tolerance to cryptococcal polysaccharide in cured cryptococcosis patients: failure of antibody secretion in vitro. Clin Exp Immunol. 1986; 65(3):639-46. PMC: 1542489. View

10.

Mozaffarian N, Berman J, Casadevall A . Immune complexes increase nitric oxide production by interferon-gamma- stimulated murine macrophage-like J774.16 cells. J Leukoc Biol. 1995; 57(4):657-62. DOI: 10.1002/jlb.57.4.657. View

11.

Casadevall A, Mukherjee J, Devi S, Schneerson R, Robbins J, Scharff M . Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. J Infect Dis. 1992; 165(6):1086-93. DOI: 10.1093/infdis/165.6.1086. View

12.

Slack J, Nahm M, Davie J . Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency. J Exp Med. 1980; 151(4):853-62. PMC: 2185832. DOI: 10.1084/jem.151.4.853. View

13.

Gordon M, Lapa E . SERUM PROTEIN ENHANCEMENT OF ANTIBIOTIC THERAPY IN CRYPTOCOCCOSIS. J Infect Dis. 1964; 114:373-7. DOI: 10.1093/infdis/114.4.373. View

14.

Han Y, Cutler J . Antibody response that protects against disseminated candidiasis. Infect Immun. 1995; 63(7):2714-9. PMC: 173363. DOI: 10.1128/iai.63.7.2714-2719.1995. View

15.

Drouhet E, SEGRETAIN G . [Inhibition of leukocyte migration in vitro by a capsular polyoside of Torulopsis (Cryptococcus) neoformans]. Ann Inst Pasteur (Paris). 1951; 81(6):674-6. View

16.

Devi S, Schneerson R, Egan W, Ulrich T, Bryla D, Robbins J . Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity. Infect Immun. 1991; 59(10):3700-7. PMC: 258941. DOI: 10.1128/iai.59.10.3700-3707.1991. View

17.

Lehner T . Serum fluorescent antibody and immunoglobulin estimations in candidosis. J Med Microbiol. 1970; 3(3):475-81. DOI: 10.1099/00222615-3-3-475. View

18.

Matthews R, Burnie J, Howat D, Rowland T, Walton F . Autoantibody to heat-shock protein 90 can mediate protection against systemic candidosis. Immunology. 1991; 74(1):20-4. PMC: 1384665. View

19.

Goldman D, Lee S, Casadevall A . Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect Immun. 1994; 62(11):4755-61. PMC: 303183. DOI: 10.1128/iai.62.11.4755-4761.1994. View

20.

Newman S, Gootee L, Bucher C, Bullock W . Inhibition of intracellular growth of Histoplasma capsulatum yeast cells by cytokine-activated human monocytes and macrophages. Infect Immun. 1991; 59(2):737-41. PMC: 257824. DOI: 10.1128/iai.59.2.737-741.1991. View